Fullsizeoutput 664d
Fullsizeoutput 47f6

Healionics

A novel vascular graft, based on our platform STAR biomaterial, to address the critical need for improved dialysis access in patients with kidney failure.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded March 2007
  • Employees 7
  • Incorporation Type C-corp
  • Website healionics.com

Company Summary

Healionics is addressing the critical need for improved means of dialysis access in patients with kidney failure. We have a synthetic vascular graft ready for human study and an exciting product pipeline, based on our platform STAR biomaterial which can improve performance of many implanted devices by preventing both infection & scarring.

Team

  • 25 years working with early stage medical device companies in range of capacities, including entrepreneurial, venture investing, and executive roles. Co-founded several cos. early in career, including two with exits worth a combined $365M. Later led regional office for $400M VC firm, and served as CEO of one of its portfolio cos. from founding thru advanced clinicals. MBA from Stanford University, M.S. from MIT, B.S. from U.S. Naval Academy.